v3.26.1
Summary of Grants Receivable Activity (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
Balance at beginning of year [1] $ 882
Grant costs expensed 1,897 [1]
Grants for equipment purchased 44 [1]
Grant fees 52 [1]
Grant funds received (2,173) [1]
Removal of balance due to deconsolidation of eXoZymes at November 14, 2024 (702) [1]
Balance at end of year [1]
[1] In 2024, eXoZymes was deconsolidated from the Company’s consolidated financial statements. As all grant-related costs were associated with eXoZymes, no grant-related figures are reported for 2024.